Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Database
Language
Journal subject
Affiliation country
Publication year range
1.
EMBO Rep ; 18(12): 2144-2159, 2017 12.
Article in English | MEDLINE | ID: mdl-29097394

ABSTRACT

Immunity to mycobacteria involves the formation of granulomas, characterized by a unique macrophage (MΦ) species, so-called multinucleated giant cells (MGC). It remains unresolved whether MGC are beneficial to the host, that is, by prevention of bacterial spread, or whether they promote mycobacterial persistence. Here, we show that the prototypical antimycobacterial molecule nitric oxide (NO), which is produced by MGC in excessive amounts, is a double-edged sword. Next to its antibacterial capacity, NO propagates the transformation of MΦ into MGC, which are relatively permissive for mycobacterial persistence. The mechanism underlying MGC formation involves NO-induced DNA damage and impairment of p53 function. Moreover, MGC have an unsurpassed potential to engulf mycobacteria-infected apoptotic cells, which adds a further burden to their antimycobacterial capacity. Accordingly, mycobacteria take paradoxical advantage of antimicrobial cellular efforts by driving effector MΦ into a permissive MGC state.


Subject(s)
Giant Cells/microbiology , Macrophages/physiology , Mycobacterium/metabolism , Nitric Oxide/metabolism , Animals , Cell Differentiation , Cells, Cultured , DNA Damage , Genes, p53/physiology , Giant Cells/metabolism , Humans , Macrophages/microbiology , Mice , Mycobacterium/immunology , Nitric Oxide/biosynthesis
SELECTION OF CITATIONS
SEARCH DETAIL